US drugs regulator issues severe pain alert on bisphosphonates.
Lenzer
Jeanne
J
D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D050723:Fractures, Bone / Q000517:prevention & control; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy; D010146:Pain / Q000139:chemically induced*
D050071:Bone Density Conservation Agents; D004164:Diphosphonates